iShares US Pharmaceuticals ETF
IHE
IHE
122 hedge funds and large institutions have $125M invested in iShares US Pharmaceuticals ETF in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $233K
Holders
122
Holding in Top 10
–
Calls
–
Puts
$233K
Top Buyers
| 1 | +$5.53M | |
| 2 | +$5.41M | |
| 3 | +$1.87M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.73M |
| 5 |
Goldman Sachs
New York
|
+$1.62M |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.51M | |
| 3 | -$1.21M | |
| 4 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$1.04M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$910K |